Chapter PDF
Keywords
- Visceral Leishmaniasis
- Pneumocystis Pneumonia
- Ocular Toxoplasmosis
- Aerosolized Pentamidine
- Pneumocystis Infection
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Joiner K, Sher A, Gaither T, et al: Evasion of alternative complement pathway of Trypanosoma cruzi results from inefficient binding of factor B. Proc Natl Acad Sci USA 83:6593–6597, 1986.
Ruppel A, McLaren DJ, Diesfield HJ, et al: Schistosoma mansoni: Escape from complement-mediated parasiticidal mechanisms following percutaneous primary infection. Eur J Immunol 14:702–708, 1984.
Sher A, Hieny S, Joiner K: Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: Dependence on the developmentally regulated synthesis of surface proteins and N-linked carbohydrate. J Immunol 137:2961–2967, 1986.
Piessens WF, Partono F, Hoffmann SL, et al: Antigen-specific suppressor T-lymphocytes in human lymphatic filariasis. N Engl J Med 307:144–148, 1982.
Lucas SB: Missing infections in AIDS. Trans R Soc Trop Med Hyg 84:34–38, 1990.
Greenson JK, Belitsos PC, Yardley JH, et al: AIDS enteropathy: Occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med 114:366–372, 1991.
Smith PD, Quinn TC, Strober W, et al: Gastrointestinal infections in AIDS. Ann Intern Med 116:63–77, 1992.
Vanek J, Jirovec O: Parasitare Pneumonie, “Interstitielle” Plasmazell Pneumonie der Frühgeburten verursachte durch Pneumocystis carinii. Zentralbl Bakteriol 158:120–127, 1952.
Dutz W: Pneumocystis carinii pneumonia. Pathol Annu 5:309–341, 1970.
Gajdusek DC: Pneumocystis carinii-Etiologic agent of interstitial plasma cell pneumonia of young and premature infants. Pediatrics 19:543–545, 1957.
Perera DR, Western KA, Johnson HD, et al: Pneumocystis carinii pneumonia in a hospital for children. JAMA 214:1074–1078, 1970.
Robbins JB, DeVita VT, Dutz W: Symposium on Pneumocystis carinii infection. NCI Monograph No. 43. National Cancer Institute, Washington, DC, 1976.
Stagno S, Pifer LL, Hughes WT, et al: Pneumocystis carinii pneumonitis in young immunocompetem infants. Pediatrics 66:56–62, 1980.
Van Der Meer G, Brug SL: Infection par Pneumocystis chez ľhomme et chez les animaux. Ann Soc Belg Med Trop 22:301–307, 1942.
Walzer PD, Shultz MG, Western KA: Pneumocystis carinii pneumonia and primary immune deficiency disease of infancy and childhood. J Pediatr 82:416–422, 1973.
Watanabe JM, Chinchinian H, Weitz C, et al: Pneumocystis carinii pneumonia in a family. JAMA 193:119–120, 1965.
Redman JC: Pneumocystis carinii pneumonia in an adopted Vietnamese infant. JAMA 230:1561–1563, 1973.
Walzer PD, Perl DP, Krogstad DJ, et al: Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80:83–93, 1974.
Dutz W, Post C, Jennings-Khodadad E, et al: Therapy and prophylaxis of Pneumocystis carinii. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1976, pp. 179–185.
Brazinsky JH, Phillips JE: Pneumocystis pneumonia transmission between patients with lymphoma. JAMA 209:1527, 1969.
Ruebush TK II, Weinstein RA, Baehner RL, et al: An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child 132:143–148, 1978.
Singer C, Armstrong D, Rosen PP, et al: Pneumocystis carinii pneumonia: A cluster of eleven cases. Ann Intern Med 82:772–777, 1975.
Walzer PD, Perl DP, Krogstad DJ, et al: Pneumocystis carinii pneumonia in the United States: Epidemologic, diagnostic and clinical features. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1976, pp. 55–63.
Winston DJ, Gale RP, Meyer DV, et al: Infectious complications of human bone marrow transplantation. Medicine 58:1–31, 1979.
Walzer PD: Pneumocystis carinii Pneumonia. Marcel Dekker, New York, 1994.
Fishman JA: Pneumocystis carinii pneumonia. In Fishman AP (ed): Pulmonary Diseases and Disorders. McGraw-Hill, New York, 1992, pp. 263–286.
Gottlieb MS, Schroff R, Shander HM: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425–1431, 1981.
Moskowitz LB, Kory P, Chan JC, et al: Unusual causes of death in Haitians residing in Miami: High prevalence of opportunistic infections. JAMA 250:1187–1191, 1983.
Fishman JA: Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother 42:995–1004, 1998.
Fishman JA: Treatment of infection due to Pneumocystis carinii. Antimicrob Agents Chemother 42:1309–1314, 1998.
Lundgren B, Cotton R, Lundgren JD, et al: Identification of Pneumocystis carinii chromosomes and mapping of five genes. Infect Immun 58:1705–1710, 1990.
Edman JC, Kovacs JA, Masur H, et al: Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519–522, 1988.
Sogin ML, Edman JC: A self-splicing intron in the small subunit rRNA gene of Pneumocystis carinii. Nucleic Acids Res 17:5349–5359, 1989.
Stringer SL, Stringer JR, Blase MA, et al: Pneumocystis carinii: Sequence from ribosomal RNA implies a close relationship with fungi. Exp Parasitol 68:450–461, 1989.
Edman JC, Edman U, Cao M, et al: Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. Proc Natl Acad Sci USA 86:8625–8629, 1989.
Edman U, Edman JC, Lundren B, et al: Isolation and expression of the Pneumocystis carinii thymidylate synthase gene. Proc Natl Acad Sci USA 86:6503–6507, 1989.
Smith JW, Bartlett MS: Diagnosis of Pneumocystis pneumonia. Lab Med 10:430–435, 1979.
Campbell WG: Ultrastructure of Pneumocystis in human lung. Arch Pathol Lab Med 93:312–324, 1972.
Vossen MEMH, Beckers PJA, Meuwissen JHETL, et al: Developmental biology of Pneumocystis carinii: An alternative view on the life cycle of the parasite. Z Parasitenkd 55:101–118, 1978.
Hughes WT: Pneumocystis carinii Pneumonitis. CRC Press, New York, 1987.
Pifer LL, Hughes WT, Murphy MJ: Propagation of Pneumocystis carinii in vitro. Pediatr Res 11:305–316, 1977.
Cushion MT: In vitro studies of Pneumocystis carinii. J Protozool 36:45S–52S, 1989.
Murphy MJ, Pifer LL, Hughes WT: Pneumocystis carinii in vitro. Am J Pathol 86:387, 1977.
Latorre CR, Sulzer AJ, Norman LG: Serial propagation of Pneumocystis carinii in cell line cultures. Appl Env Microbiol 33:1204–1206, 1977.
Smith JW, Bartlett MS, Queener SF: In vitro cultivation of Pneumocystis. Development of models and their use to discover new drugs for therapy and prophylaxis of Pneumocystis carinii pneumonia. In Walzer PD (ed): Pneumocystis carinii Pneumonia. Marcel Dekker, New York, 1994, pp. 487–510.
Walzer PD, Schnelle V, Armstrong D, et al: A new experimental model for Pneumocystis carinii infection. Science 197:177–179, 1977.
Hughes WT, Bartley DL, Smith BM: A natural source of infection due to Pneumocystis carinii. J Infect Dis 147:595, 1983.
Veda K, Goto Y, Yamazaki S, et al: Chronic fatal pneumocystosis in nude mice. Jpn J Exp Med 47:475–482, 1977.
Frenkel JK, Good JT, Shultz JA: Latent Pneumocystis infection of rats: Relapse and chemotherapy. Lab Invest 15:1559–1577, 1966.
Frenkel JK: Pneumocystis jiroveci n. sp. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1976, pp. 13–30.
Hendley JO, Weller TH: Activation and transmission in rats of infection with Pneumocystis. Proc Soc Exp Biol Med 137:1401–1404, 1971.
Bartlett MS, Fishman JA, Durkin MM, et al: Pneumocystis carinii: Improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol 70:100–106, 1990.
Shellito J, Suzara VV, Blumenfeld W, et al: A new model of Pneumocystis carinii infection in mice selectively depleted of help of T lymphocytes. J Clin Invest 85:1686–1693, 1990.
Harmsen AG, Stankiewiez M: Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 172:937–946, 1990.
Furuta T, Veda K, Fujiwara K, et al: Cellular and humoral immune response of mice subclinically infected with Pneumocystis carinii. Infect Immun 47:544–548, 1985.
Furuta TK, Ueda K, Fujiwara K: Effect of T-cell transfer on Pneumocystis carinii infection in nude mice. Jpn J Exp Med 54: 57–64, 1984.
Beck JM, Liggitt HD, Brunette EN, et al: Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immun 59:3859–3862, 1991.
Murray HW, Gellene RA, Libby DM: Activation of tissue macrophages from AIDS patients: In vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol 135:2374–2377, 1985.
Brzosko WJ, Nowoslawski A: Identification of Pneumocystis carinii antigens in tissues. Bull Acad Pol Sci 13:49–54, 1965.
Graves DC: Immunologic studies of Pneumocystis carinii. J Protozool 36:60–69, 1989.
Fishman JA: Prevention of infection due to Pneumocystis carinii in transplant recipients. Clin Infect Dis 33:1397–405, 2001.
Hughes WT: Recent advances in serodiagnosis of Pneumocystis carinii. Chest 89:764–765, 1986.
Fisher DJ, Gigliotti F, Zauderer M, et al: Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection. Infect Immun 59:3372–3376, 1991.
Herrod HG, Valenski WR, Woods DR, et al: The in vitro response of human lymphocytes to Pneumocystis carinii antigen. J Immunol 126:59–61, 1981.
Giggliotti F, Hughes WT: Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 81:1666–1668, 1988.
Hagler DN, Deepe GS, Pogue CL, et al: Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin Exp Immunol 74:7–13, 1988.
Masur H, Jones TC: The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 147:157–170, 1978.
Hughes WT, Feldman S, Aur RJA, et al: Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36:2004–2009, 1975.
Masur H, Ognibene FP, Yarchoan R, et al: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 111:223–231, 1989.
Hughes WT, Johnson WW: Recurrent Pneumocystis carinii pneumonia following apparent recovery. J Pediatr 79:755–759, 1971.
Hughes WT, Price RA, Sisko F, et al: Protein calorie malnutrition: A host determinant for Pneumocystis carinii infection. Am J Dis Child 128:44–550, 1974.
Hughes WT, Sanyal SK, Price RA: Signs, symptoms and pathophysiology of Pneumocystis carinii pneumonitis. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1976, pp. 77–88.
Jacobson MA, Mills J: Serious cytomegalovirus disease in ac-quired immunodeficiency syndrome (AIDS): Clinical findings, diagnosis, and treatment. Ann Intern Med 108:585–594, 1988.
Wang NS, Huang SN, Thurlbeck WM: Combined Pneumocystis carinii and cytomegalovirus infection. Arch Pathol Lab Med 90:529–535, 1970.
Bozzette SA, Arcia J, Bartok AE, et al: Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis 165:93–98, 1992.
Lyons HA, Vinijchaikul K, Hennigar GR: Pneumocystis carinii pneumonia unassociated with other disease. Arch Intern Med 108:173–180, 1961.
Meuwissen JHET, Leeuwenberg ADEM: A microcomplement fixation test applied to infection with Pneumocystis carinii. Trop Geogr Med 24:282–291, 1972.
Meyer JD, Pifer LL, Sale GE, et al: The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 120:181–182, 1979.
Meuwissen JHET, Tauber I, Leeuwenberg ADEM, et al: Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis 136:43–49, 1977.
Norman L, Kagan IG: Some observations on the serology of Pneumocystis carinii infections in the United States, Infect Immunol 8:317–321, 1973.
Pifer LL: Serodiagnosis of Pneumocystis carinii. Chest 87:698–700, 1985.
Kovacs JA, Hiemenz JW, Macher AM, et al: Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663–671, 1984.
Kwok S, O’Donnell JJ, Wood IS: Retinal cotton-wool spots in a patient with Pneumocystis carinii infection. N Engl J Med 307: 184–185, 1982.
Scott GB, Hutto C, Makuch RW, et al: Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 321:1971–1976, 1989.
Sirotzky L, Memoli V, Roberts JL, et al: Recurrent Pneumocystis pneumonia with normal chest roentgenograms. JAMA 240:1513–1515, 1978.
Turbiner EH, Yen SDJ, Rosen PP, et al: Abnormal gallium scintigraphy in Pneumocystis carinii pneumonia with a normal chest radiography. Radiology 127:437–438, 1978.
Goodell B, Jacobs JB, Powell RD, et al: Pneumocystis carinii: The spectrum of diffuse interstitial pneumonia in patients with neoplastic disease. Ann Intern Med 72:337–340, 1970.
Doppman JL, Geelhoed GW: Atypical radiographic features in Pneumocystis carinii pneumonia. In Dutz W, Robbins JB, DeVita VT Jr (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1976, pp. 89–97.
Cross AS, Steigbigel RT: Pneumocystis carinii pneumonia presenting as localized nodular densities. N Engl J Med 291:831–832, 1974.
Luddy RE, Champion LAA, Schwartz AD: Pneumocystis carinii pneumonia with pneumatocoele formation. Am J Dis Child 131: 470–471, 1973.
Levenson SM, Warren RD, Richman SD, et al: Abnormal pulmonary gallium accumulation in P. carinii pneumonia. Radiology 119:395–398, 1976.
Fishman JA, Strauss HW, Fischman AJ, et al: Imaging of Pneumocystis carinii pneumonia with 111In-labelled non-specific polyclonal IgG: An experimental study in rats. Nucl Med Comm 12: 175–187, 1991.
Fishman JA: Radiologic approach to the diagnosis and management of Pneumocystis carinii. In Walzer P (ed): Pneumocystis carinii Pneumonia. Marcel Dekker, New York, 1994, pp. 415–438.
Hopewell PC: Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 102:747–752, 1985.
Kovacs JA, Ng VL, Masur H, et al: Diagnosis of P. carinii pneumonia: Improved detection in sputum with use of monoclonal antibiotics. N Engl J Med 318:589–593, 1988.
Stover DE, Zaman MB, Hajdu SI, et al: Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immuno-compromised host. Ann Intern Med 101:1–7, 1984.
Awen C, Baltzan M: Systemic dissemination of Pneumocystis carinii pneumonia. Can Med Assoc J 104:809–812, 1971.
Coulman CU, Greene I, Archibald RWR: Cutaneous Pneumocystis. Ann Intern Med 106:396–398, 1987.
Fishman JA: Case records of the Massachusetts General Hospital. N Engl J Med 332:249–258, 1995.
Raviglionne MC: Extrapulmonary pneumocystosis: The first fifty cases. Rev Infect Dis 12:1127–1138, 1990.
Lau WK, Young LS, Remington JS: Pneumocystis carinii pneumonia: Diagnosis by examination of pulmonary secretions. JAMA 236:2399–2402, 1976.
Bigby PD, Margolskee D, Curtis J, et al: Usefulness of induced sputum in diagnosis of pneumonia in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 133:515–518, 1986.
Bigby TD, Margolskee D, Curtis JL, et al: The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 133:515–518, 1986.
Kovacs JA, Gill V, Swann JC, et al: Prospective evaluations of monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet 2:1–3, 1986.
Lim SK, Eveland WC, Porter RJ; Direct fluorescent-antibody method for the diagnosis of Pneumocystis carinii pneumonitis from sputa or tracheal aspirates from humans. Appl Microbiol 27:144–149, 1974.
Baughman RP: Current methods of diagnosis. In PD Walzer (ed): Pneumocystis carinii Pneumonia. Marcel Dekker, New York, 1994, pp. 381–402.
Pennington JE, Feldman NT: Pulmonary infiltrates and fever in patients with hematologic malignancy: Assessment of transbronchial biopsy. Am J Med 62:581–587, 1977.
Blumenfeld W, Wager E, Hadley WK: Use of transbronchial biopsy for diagnosis of opportunistic pulmonary infections in acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 81:1–5, 1984.
Broaddus C, Dake MD, Stulbarg MS, et al: Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 102:747–752, 1985.
Burt ME, Flye WW, Webber BL, et al: Prospective evaluation of aspiration needle, cutting needle transbronchial, and open lung biopsy in patients with pulmonary infiltrates. Ann Thorac Surg 32:146–153, 1981.
Coleman DL, Dodek PM, Luce JM, et al: Diagnostic utility of fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome. Am Rev Respir Dis 128:795–799, 1983.
Springmeyer SC, Silvestri, RC, Sale GE, et al: Role of transbronchial biopsy for the diagnosis of diffuse pneumonia in immunocompromised marrow transplant recipients. Am Rev Respir Dis 126:763–765, 1982.
Chaudhary S, Hughes WT, Feldman S, et al: Percutaneous transthoracic needle aspiration of the lung. Am J Dis Child 131:902–906, 1977.
Rossiter SJ, Miller DC, Churg AM, et al: Open lung biopsy in the immunosuppressed patient. J Thorac Cardiovasc Surg 77:338–345, 1979.
Young RC, DeVita VT Jr: Treatment of Pneumocystis carinii pneumonia. In Robbins JB, DeVita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1976, pp. 193–198.
Haverkos HW: PCP therapy project group: Assessment of therapy for Pneumocystis carinii pneumonia. Am J Med 76:501–508, 1984.
Hughes WT, Feldman S, Chaudhary SC, et al: Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 92:285–291, 1978.
Hughes WT, Feldman S, Sanyal SK: Treatment of Pneumocystis carinii pneumonitis with trimethoprim/sulfamethoxazole. Can Med Assoc J 112:47S–50S, 1975.
Hughes WT, McNabb PC, Makres TD, et al: Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother 5:289–293, 1974.
Wharton JM, Coleman DL, Wofsy CB, et al: Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 105:37–44, 1986.
Kluge RM, Spaulding DM, Spain JA: Combination of pentamidine and trimethoprim-sulfamethoxazole in the therapy of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 13:975–978, 1978.
Hughes WT, Kuhn S, Chaudhary S, et al: Successful chemoprophylaxis of Pneumocystis carinii pneumonia pneumonitis. N Engl J Med 297:1419–1426, 1977.
Lau WK, Young LS: Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 295:716–71, 1976.
Winston DJ, Lau WK, Gale RP, et al: Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 97:762–769, 1980.
Young LS: Treatment of Pneumocystis carinii pneumonia in adults with trimethoprim/sulfamethoxazole. Rev Infect Dis 4:608–613, 1982.
Ivady G, Paldy L: Ein neues Behandlungserfarhren der interstitiellen plasmazelligen Pneumonie Frühgeborener mit fünfwertigen Stibium und aromatischen Diamidinen. Monatsschr Kinderheilkd 106:10–14, 1958.
Western KA, Perera DR, Schultz MG: Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 73:695–702, 1970.
Hughes WT, Smith BL: Efficacy of diaminodiphenyl sulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother 26:436–440, 1984.
Hughes WT, Smith-McCain BL: Effects of sulfonyl urea compounds on Pneumocystis carinii. J Infect Dis 153:944–947, 1984.
Leoung GS, Mills J, Hopewell PC, et al: Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 105:45–48, 1986.
Medina I, Mills J, Leoung G, et al: Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 323:776–782, 1990.
Metroka CE, McMechan MF, Andrada R, et al: Failure of prophylaxis with dapsone in patients taking dideoxyinosine. N Engl J Med 325:737, 1991.
Noskin GA, Murphy RL, Black JR, et al: Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin Infect Dis 14:183–188, 1992.
Post C, Fakoughi T, Dutz W, et al: Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine and pyrimethamine combination. Curr Ther Res 13:273–279, 1971.
Toma E, Fournier S, Poisson M, et al: Clindamycin with primaquine for Pneumocystis carinii pneumonia. Lancet 1:1046–1048, 1989.
Whisnant JK, Buckley RH: Successful pyrimethamine-sulfadiazine therapy of Pneumocystis pneumonia in infants with X-linked immunodeficiency with hyper IgM. In Robbins JB, De-Vita VT Jr, Dutz W (eds): Symposium on Pneumocystis carinii Infection. NCI Monograph 43. National Cancer Institute, Washington, DC, 1975, pp. 211–216.
Allegra CJ, Chabner BA, Tuazon CU, et al: Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 317:978–985, 1987.
Polsen DC, Kovacs JA, Lipschik GY: Folate antagonists in the treatment of Pneumocystis carinii pneumonia. In PD Walzer (ed): Pneumocystis carinii Pneumonia. Marcel Dekker, New York, 1994, pp. 545–560.
Sattler FR, Allegra CJ, Verdegam TD, et al: Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia. J Infect Dis 161:91–96, 1990.
Allegra CJ, Kovacs JA, Chabner BA, et al: Potent in vivo and in vitro activity of a lipid soluble antifolate, trimetrexate, against Pneumocystis carinii. Clin Res 34:674A, 1986.
Falloon J, Kovacs J, Hughes W, et al: A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 325:1534–1538, 1991.
Golden JA, Sjoerdsma A, Santi DV: Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. West J Med 141:613–623, 1984.
Bozzette SA, Sattler FR, Chiu J, et al: A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1451–1457, 1990.
Gagnon S, Boota AM, Fisch MA, et al: Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1444–1450, 1990.
McGowan JE Jr, Chesney PJ, Crossley KB, et al: Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J infect Dis 165:1–13, 1992.
Montaner JSG, Lawson LM, Levitt N. et al: Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodefi ciency syndrome (AIDS). Ann Intern Med 113:14–20, 1990.
Hughes WT, Rivera GK, Schell MJ, et al: Successful intermittent prophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 316:1627–1632, 1987.
Hughes WT, Price RA, Kim HK, et al: Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 82:404–415, 1973.
Fischl MA: Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 105:pp 629, 1986.
Hughes WT: Limited effect of trimethoprim sulfamethoxazole prophylaxis on Pneumocystis carinii. Antimicrob Agents Chemother 16:333–335, 1979.
Hughes WT: Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center. J Infect Dis 150:305–306, 1984.
Gottlieb M, Knight S, Mitsuyasu R, et al: Prophylaxis of Pneumocystis carinii infection in acquired immunodeficiency syndrome (AIDS) with pyrimethamine/sulfadoxine (Fansidar). Lancet 2:398–399, 1984.
Feldman HA: Toxoplasmosis: An overview. Bull NY Acad Med 50:110–127.
Janku J: Pathogenesis and pathologic anatomy of coloboma of macula lutea in eye of normal dimensions, and in microphthalmic eye with parasites in return. Cas Lek Clsk 62:1021–1027, 1923.
Jones TC, Hirsch JG: The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosome fusion with phagocytic vacuoles containing living parasites. J Exp Med 136:1173–1194, 1972.
Raisanen S: Toxoplasmosis transmitted by blood transfusions. Transfusion 18:329–332, 1978.
Michaels MG, Wald ER, Ficker FJ, et al: Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 14:847–851, 1992.
Leak D, Meghji M: Toxoplasmic infection in cardiac disease. Am J Cardiol 43:841–849, 1979.
Anderson SE Jr, Remington JS: Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med 139:1154–1174, 1974.
Araujo FG: Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice. Infect Immun 59:1614–1619, 1991.
McLeod R, Remington JS: Influence of infection with toxoplasma on macrophage function, and role of macrophages in resistance to toxoplasma. Am J Trap Med Hyg 26:170–186, 1977.
Lindberg RE, Frenkel JK: Toxoplasmosis in nude mice. J Parasitol 63:210–221, 1977.
Frenkel JK: Effects of cortisone, total body radiation and nitrogen mustard on chronic latent toxoplasmosis. Am J Pathol 33:618–619, 1957.
Strannegard O, Lycke E: Effect of antithymocyte serum on experimental toxoplasmosis in mice. Infect Immun 5:769–774, 1972.
Remington JS, Krahenbuhl JL, Mendenhall JW: A role for activated macrophages in resistance to infection with toxoplasma. Infect Immun 6:829–834, 1972.
Jones TC, Len L, Hirsch J: Assessment in vitro of immuniry against Toxoplasma gondii. J Exp Med 171:466–482, 1975.
Hirsch R, Burke BA, Kersey JH: Toxoplasmosis in bone marrow transplant recipients. J Pediatr 105:426–428, 1984.
Jehn V, Fink M, Gundlach P: Lethal cardiac and cerebral toxoplasmosis in a patient with acute myeloid leukemia after successful allogenic bone marrow transplantation. Transplantation 38:430–433, 1984.
Nicholdon DH, Wolchok EB: Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch Ophthalmol 94:248–257, 1976.
O’Connor GR, Frenkel JK: Dangers of steroid treatment in toxolasmosis. Arch Ophthalmol 94:213, 1976.
Rose AG, Uys CJ, Novitsky D, et al: Toxoplasmosis of donor and recipient hearts after heterotopic cardiac transplantations. Arch Pathol Lab Med 107:368–373, 1983.
Ryning FW, McLeod R, Madox JC, et al: Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 84:47–49, 1979.
Swartzberg JE, Krahenbuhl JL, Remington JS: Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Cerynebacterium parvum. Infect Immun 12:1037–1043, 1975.
Wong B, Gold JWM, Brown AE, et al: Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers. Ann Intern Med 100:36–42, 1984.
Ruskin J, Remington JS: Toxoplasmosis in the compromised host. Ann Intern Med 84:193–199, 1976.
Barlotta FM, Odhoa M Jr, Neu HC, et al: Toxoplasmosis, lymphoma or both? Ann Intern Med 70:517–528, 1979.
Herb HM, Jontofsoh R, Loffler HD, et al: Toxoplasmosis after renal transplantation. Clin Nephrol 8:529–532, 1978.
Luft BJ, Naot Y, Araujo FG, et al: Primary and reactivated toxoplasma infection in patients with cardiac transplant: Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med 99:27–31, 1983.
Whiteside JD, Begent RHJ: Toxoplasma encephalitis complicating Hodgkin’s disease. J Clin Pathol 28:443–445, 1975.
Brooks RG, McCabe RE, Remington JS: Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis 9: 1055–1062, 1987.
McCabe RE, Brooks RG, Dorfman RF, et al: Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 9:754–774, 1987.
Siim JC: Acquired toxoplasmosis: Report of seven cases with strongly positive serologic reactions. JAMA 147:1651–1654, 1951.
Gard S, Magnusson HJ: Glandular form of toxoplasmosis in connection with pregnancy. Acta Med Scand 141:59–64, 1951.
Welch PC, Masur H, Jones TC, et al: Serologic diagnosis of acute lymphadenopathic toxoplasmosis. J Infect Dis 142:256–264, 1980.
Wolf A, Cowen D, Paige B: Human toxoplasmosis: Occurrence in infants with encephalomyelitis—Verification by transmission to animals. Science 89:226–227, 1939.
Rollins DF, Tabbara KF, O’Connor GR, et al: Detection of toxoplasma antigen and antibody in ocular fluids in experimental ocular toxoplasmosis. Arch Ophthalmol 101:455–457, 1983.
Siegel S, Lunde M, Gelderman A, et al: Transmission of toxoplasmosis by leukocyte transfusion. Blood 37:388–394, 1971.
Stinson EB, Biber CP, Griepp RB, et al: Infectious complications after transplantation in man. Ann Intern Med 74:22–36, 1971.
Dummer JS, Bahnson HT, Griffith BP, et al: Infections in patients on cyclosporine and prednisone following cardiac transplantation. Transplant Proc 14:2779–2781, 1983.
Luft BJ, Naot Y, Araujo FG, et al: Primary and reactivated toxoplasma infection in patients with cardiac transplants. Ann Intern Med 99:27–31, 1983.
Hakin M, Wreghitt TG, English TAH, et al: Significance of donor transmitted disease in cardiac transplantation. Heart Transplant 4:302–306, 1985.
Hakin M, Esmore D, Wallwork J, et al: Toxoplasmosis in cardiac transplantation. Br Med J 292:1108–1109, 1986.
Pomeroy C, Filice GA: Pulmonary toxoplasmosis: A review. Clin Infect Dis 14:863–870, 1992.
Fishman J: Pneumocystis carinii pneumonia. In Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM (eds): Fishan’s Pulmonary Diseases and Disorders, 3rd ed. McGraw-Hill, New York, 1998, pp. 2313–2332.
Jacobs F, Depierreux M, Goldman M, et al: Role of broncho-alveolar lavage in diagnosis of disseminated toxoplasmosis. Rev Infect Dis 13:637–641, 1990.
Oksenhendler E, Cadranel J, Sarfati C, et al: Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome. Am J Med 88:18N–21N, 1990.
Snider WD, Simpson DM, Neilsen S, et al: Neurological complications of acquired immunodeficiency syndrome: Analysis of 50 patients. Ann Neural 14:403–418, 1983.
Ghatak NR, Sawyer DR: A morphologic study of opportunistic cerebral toxoplasmosis. Acta Neuropathol 42:217–221, 1978.
Kerstin F, Newmann J: “Malignant lymphoma” of the brain following renal transplantation. Acta Neuropathol 6:131–133, 1975.
Luft BJ, Brooks RG, Conley FK, et al: Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 252:913–917, 1984
Luft BJ, Remington JS: Toxoplasmosis of the central nervous system. In Remington JS, Swartz M (eds): Current Clinical Topics in Infectious Disease, Vol. 5. McGraw-Hill, New York, 1985, pp. 315–358.
Luft BJ, Remington JS: Toxoplasmic encephalitis. J Infect Dis 157:1–6, 1988.
Powell HC, Gibbs JC Jr, Lorenzo AM, et al: Toxoplasmosis of the central nervous system in the adult: Electron microscopic observations. Acta Neuropathol 41:211–216, 1978.
Schulkof LA, Russell JR: Intracerebral toxoplasmosis presenting as a mass lesion. Surg Neural 4:9–11, 1975.
Slavick HE, Lipman IJ: Brain stem toxoplasmosis complicating Hodgkin’s disease. Arch Neural 34:636–637, 1977.
Wanke C, Tuazon CU, Kovacs A, et al: Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: Diagnosis and response to therapy. Am J Trop Med Hyg 36:509–516, 1987.
Menges HW, Fischer E, Valavanis A, et al: Cerebral toxoplasmosis in the adult. J Comput Assist Tomogr 3:413–416, 1979.
Ciricillo SF, Rosenblum ML: Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 73:720–724, 1990.
Shepp DH, Hackman RC, Conley FK, et al: Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture. Ann Intern Med 103:218–221, 1985.
Hofflin JM, Remington JS: Tissue culture isolation of toxoplasma from blood of a patient with AIDS. Arch Intern Med 145:925–926, 1985.
Dorfman RF, Remington JS: Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med 289: 878–881, 1973.
Araujo FG, Remington JS: Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis 141:144–150, 1980.
Brooks RG, Sharma SD, Remington JS: Detection of Toxoplasma gondii antigens by a dot-immunobinding technique. J Clin Microbiol 21:113–116, 1985.
Sabin AV, Ruchman I: Characteristics of toxoplasma neutralizing antibody. Proc Soc Exp Biol Med 51:1–6, 1942.
Desmonts G: Definitive serologic diagnosis of ocular toxoplasmosis. Arch Ophthalmol 76:839–851, 1966.
Potasman I, Resnick L, Luft BJ, et al: Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:49–51, 1988.
Sabin A, Feldman HA: Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 108:660–663, 1978.
Remington JS, Eimstad WM, Araujo FG: Detection of immunoglobulin M antibodies with antigen-tagged latex particles in an immunosorbent assay. J Clin Microbiol 17:939–941, 1983.
Remington JS, Miller MJ, Brownlee I: IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med 71:855–866, 1968.
Desmonts G, Remington JS: Direct agglutination test for diagnosis of toxoplasma infection: Method for increasing sensitivity and specificity. J Clin Microbiol 11:562–568, 1980.
McCabe RE, Gibbons D, Brooks RG, et al: Agglutination test for diagnosis of toxoplasmosis in AIDS. Lancet 2:680, 1983.
Siegel JP, Remington JS: Comparison of methods for quantitating antigen specific immunoglobulin M antibody with a reverse enzyme linked immunoabsorbent assay. J Clin Microbiol 18:63–70, 1983.
Walls KW, Bullock SL, English DK: Use of the enzyme-linked immunosorbent assay (ELISA) and its microadaptation for the serodiagnosis of toxoplasmosis. J Clin Microbiol 5:273–277, 1977.
Wielaard F, van Gruighuigsen H, Duermeyer W, et al: Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin M antibodies. J Clin Microbiol 17:981–987, 1983.
Hakes TB, Armstrong D: Toxoplasmosis: Problems in diagnosis and treatment. Cancer 52:1535–1540, 1983.
Cohn JA, McMeeking A, Cohen W, et al: Evaluation of the policy of empiric treatment of suspected toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 86:521–527, 1989.
Dannemann B, McCutchan JA, Israelski D, et al: Treatment of toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 116:33–43, 1992.
Haverkos HW: Assessment of therapy for toxoplasma encephalitis. Am J Med 82:907, 1987.
Danneman BR, Israelski DM, Remington JS: Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med 148:2477–2482, 1988.
Katlama C: Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. Eur J Clin Microbiol Infect Dis 10:189–191, 1991.
Heald A, Flepp M, Chave J-P, et al: Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 115:760–763, 1991.
Kovacs JA, Allegra CJ, Chabner BA, et al: Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii. J Infect Dis 155:1027–1032, 1987.
Araujo FG, Prokocimer P, Remington JS: Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis. J Infect Dis 165:788, 1992.
Grossman P, Remington J: The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 28:445–455, 1979.
Hakim M: Toxoplasmosis in cardiac transplantation. Br Med J 92:41108, 1986.
Leport C, Vilde JL, Katlama C, et al: Failure of spiramycin to prevent neurotoxoplasmosis in immunosuppressed patients. JAMA 255:2290, 1986.
Guerrant RL, Bobak DA: Bacterial and protozoal gastroenteritis. N Engl J Med 325:327–340, 1991.
Laughon BE, Druckman DA, Vernon A, et al: Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 94:984–993, 1988.
Miller RA, Holmberg R Jr, Clausen CR: Life-threatening diarrhea caused by Cryptosporidium in a child undergoing therapy for acute lymphocytic leukemia. J Pediatr 103:256–259, 1983.
Moura H, Fernandes O, Viola JPB, et al: Enteric parasites and HIV infection: Occurrence in AIDS patients in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz Rio de Janeiro 84:527–533, 1989.
Soave R, Armstrong D: Cryptosporidium and cryptosporidiosis. Rev Infect Dis 8:1012–1023, 1986.
Soave R, Johnson WD Jr: Cryptosporidium and Isospora belli infections. J Infect Dis 157:225–229, 1988.
Vuorio A, Jokipii AMM, Jokipii L: Cryptosporidium in asymptomatic children. Rev Infect Dis 13:261–264, 1991.
Wolfson JS, Richter JM, Waldron MA, et al: Cryptosporidiosis in immunocompetent patients. N Engl J Med 213:1278–1282, 1985.
Connolly GM, Dryden MS, Shanson DC, et al: Cryptosporidial diarrhea in AIDS and its treatment. Gut 29:593–597, 1988.
Moore JD, Buster SH: Intestinal parasites in Haitian entrants. J Infect Dis 150:965, 1984.
Fleming AF: Opportunistic infections in AIDS in developed and developing countries. Trans R Soc Trop Med Hyg 84:1–6, 1990.
Colebunders R, Lusakumuni K, Nelson AM, et al: Persistent diarrhoea in Zairian AIDS patients: An endoscopic and histological study. Gut 29:1687–1691, 1988.
Whiteside ME, Barkin JS, May RG, et al: Enteric coccidiosis among patients with the acquired immunodeficiency syndrome. Am J Trop Med Hyg 33:1065–1072, 1984.
Smith PD, Lane HC, Gill VJ, et al: Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:328–333, 1988.
Bogaerts J, Lepage P, Rouvroy D, et al: Cryptosporidium spp., a frequent cause of diarrhea in central Africa. J Clin Microbiol 20:874–876, 1984.
Shepherd RC, Reed CL, Sinha GP: Shedding of oocysts of Cryptosporidium in immunocompetent patients. J Clin Pathol 41:1104–1106, 1988.
Caprioli A, Gentile G, Baldassarri L, et al: Cryptosporidium as a common cause of childhood diarrhoea in Italy. Epidemiol Infect 102:537–540, 1989.
Current WL, Reese NC, Ernst JV, et al: Human cryptosporidiosis in immunocompetent and immunodeficient persons: Studies of an outbreak and experimental transmission. N Engl J Med 308:1252–1257, 1983.
DuPont HL: Cryptosporidiosis and the healthy host. N Engl J Med 312:1319–1320, 1985.
Weisburger WR, Hutcheon DF, Yardley JH, et al: Cryptosporidiosis in an immunosuppressed renal-transplant recipient with IgA deficiency. Am J Clin Pathol 72:473–478, 1979.
Darban H, Enriquez J, Sterling CR, et al: Cryptosporidiosis facilitated by murine retroviral infection with LP-BM5. J Infect Dis 164:741–745, 1991.
Tzipori S: Cryptosporidiosis in animals and humans. Microbiol Rev 47:84–96, 1983.
Gentile G, Venditti M, Micozzi A, et al: Cryptosporidiosis in patients with hematologic malignancies. Rev Infect Dis 13:842–846, 1991.
Gentile G, Caprioli A, Donelli G, et al: Asymptomatic carriage of Cryptosporidium in two patients with leukemia [letter]. Am J Infect Control 18:127–128, 1990.
Soave R, Ma P: Cryptosporidiosis: Traveler’s diarrhea in two families. Arch Intern Med 145:7–72, 1983.
Horowitz MA, Hughes JM, Craun GF: Outbreaks of waterborne disease in the United States. J Infect Dis 133:588–593, 1974.
Hayes EB, Matte TD, O’Brien TR, et al: Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N Engl J Med 320:1372–1376, 1989.
Martino P, Gentile G, Caprioli A, et al: Hospital-acquired cryptosporidiosis in a bone marrow transplantation unit. J Infect Dis 158:647–648, 1988.
Roncoroni AJ, Gomez MA, Mera J, et al: Cryptosporidium infection in renal transplant. J Infect Dis 160:559, 1989.
Rehg JE, Hancock ML, Woodmansee DB: Characterization of a dexamethasone-treated model of Cryptosporidial infection. J Infect Dis 158:1406–1407, 1988.
Dryden MS, Shanson DC: The microbial causes of diarrhea in patients infected with the human immunodeficiency virus. J Infect Dis 17:107–114, 1988.
Kaljot KT, Ling JP, Gold JW, et al: Prevalence of acute enteric viral pathogens in acquired immunodeficiency syndrome patients with diarrhea. Gastroenterology 97:1031–1032, 1989.
Knight R, Wright SG: Progress report: Intestinal protozoa. Gut 19:940, 1978.
Kotler DP, Francisco A, Clayton F, et al: Small intestinal injury and parasitic diseases in AIDS. Ann Intern Med 113:444–449, 1990.
Ungar B: Enzyme-linked immunoassay for detections of Cryptosporidium antigens in fecal specimens. J Clin Microbiol 28:2491–2495, 1990.
Erlandsen SL, Chase DG: Morphological alterations in the microvillous border of villous epithelial cells produced by intestinal microorganisms. Am J Clin Nutr 27:1277–1286, 1974.
Kibbler CC, Smith A, Hamilton-Dutoit SJ, et al: Pulmonary cryptosporidiosis occurring in a bone marrow transplant patient. Scand J Infect Dis 19:581–584, 1987.
Ma P, Villanueva TG, Kaufman D, et al: Respiratory cryptosporidiosis in the acquired immune deficiency syndrome: Use of modified cold Kinyoun and Hemacolor stains for rapid diagnosis. JAMA 252:1298–1301, 1984.
Meisel JL, Perera DR, MeLigro C, et al: Overwhelming watery diarrhea associated with Cryptosporidium in an immunosuppressed patient. Gastroenterology 70:1156–1160, 1976.
Cron R, Sherry D: Reiter’s syndrome associated with cryptosporidial gastroenteritis. J Rheumatol 10:1062–1063, 1995.
Moskovitz BL, Stanton TL, Kusmierek JJ: Spiramycin therapy for cryptosporidial diarrhoea in immunocompromised patients. J Antimicwb Chemother 22:189–191, 1988.
Portnoy D, Whiteside ME, Buckley E III, et al: Treatment of intestinal cryptosporidiosis with spiramycin. Ann Intern Med 101:202–204, 1984.
Louie E, Borkowsky W, Klesius PK, et al: Treatment of cryptosporidiosis with oral bovine transfer factor. Clin Immunol Immunopathol 44:329–334, 1987.
Saxon A, Weinstein W: Oral administration of bovine colostrum anticryptosporidia antibody fails to alter the course of human cryptosporidiosis. J Parasitol 73:413–415, 1987.
Cook DJ, Kelton JG, Stanisz AM, et al: Somatostatin treatment for cryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:708–709, 1988.
Cello JP, Grendell JH, Basuk P, et al: Effect of octreotide on refractory AIDS-associateddiarrhea. Ann Intern Med 115:705–710, 1991.
Nousbaum JB, Robaszkiewicz M, Cauvin JM, et al: Treatment of intestinal cryptosporidiosis with zidovudine and SMS 201–995, a somatostatin analog. Gastroenterology 101:874, 1991.
Godiwala T, Yaeger R: Isospora and traveler’s diarrhea, Ann Intern Med 106:908–909, 1987.
DeHovitz A, Pape JW, Boney M, et al: Clinical manifestations and therapy of Isospora belli infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 315:87–90, 1986.
DeHovitz J: Management of Isospora belli infections in AIDS patients. Infect Med 5:437–440, 1988.
Pape JW, Verdier RI, Johnson WD Jr: Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 320:1044–1047, 1989.
Bryan RT, Cali A, Owen RL, et al: Microsporidia: Opportunistic pathogens in patients with AIDS. In Sun T (ed): Progress in Clinical Parasitology, Vol. II. Field & Wood, New York, 1991, pp. 1–26.
Desportes I, Charpentier Y, Gallian A, et al: Occurrence of a new microsporidian: Enterocytozoon bieneusi n.g., n.sp., in the enterocysts of a human patient with AIDS. J Protozool 32:250–254, 1985.
Orenstein JM, Chiang J, Steinberg W, et al: Intestinal microsporidiosis as a cause of diarrhea in HIV-infected patients: A report of 20 cases. Hum Pathol 21:475–481, 1990.
Cali A, Owen RL: Microsporidiosis. In Balows A, Hausler WJ Jr, Ohashi M et al (eds): Laboratory Diagnosis of Infectious Diseases: Principles and Practice. Springer-Verlag, New York, 1988, pp. 929–950.
Cali A, Owen RL: Intracellular development of Enterocytozoon, a unique microsporidian found in the intestine of AIDS patients. J Protozool 37:145–155, 1990.
Weber R, Bryan RT, Owen RL, et al (Enteric Opportunistic Infections Working Group): Improved light-microscopical detection of Microsporidia spores in stool and duodenal aspirates. N Engl J Med 326:161–166, 1992.
Genta RM: Global prevalence of strongyloidiasis: Critical review with epidemiologic insight into the prevention of disseminated disease. Rev Infect Dis 11:755–767, 1989.
Neva FA: Biology and immunology of human strongyloidiasis. J Infect Dis 153:397–406, 1986.
Igra-Siegman Y, Kapila R, Sen P, et al: Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3:397–407, 1981.
Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine 57: 527–544, 1978.
Rivera E, Maldonado N, Velez-Garcia E, et al: Hyperinfection with Strongyloides stercoralis. Ann Intern Med 72:199–204, 1970.
Nucci M, Portugal R, Pulcheri W, et al: Fatal strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis 21:675–677, 1995.
Rogers W, Nelson B: Strongyloidiasis and malignant lymphoma. JAMA 195:173–175, 1966.
Purtilo DT, Meyers WM, Connor DH: Fatal strongyloidiasis in immunosuppressed patients. Am J Med 56:488–493, 1974.
Maayan S, Wormser GP, Widerhorn J, et al: Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med 83:945–948, 1987.
Kuberski TT, Gabor EP, Bourdreaux D: Disseminated strongyloidiasis—A complication of the immunosuppressed host. West J Med 122:504–508, 1975.
Cohen J, Spry CJF: Strongyloides stercoralis infection and small intestinal lymphoma. Parasitol Immunol 1:167–169, 1979.
De Oliviera RB, Voltarelli JC, Meneghelli VG: Severe strongyloidiasis associated with hypogammaglobulinemia. Parasitol Immunol 3:4165–169, 1981.
Kramer MR, Gregg PA, Goldstein M, et al: Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: Diagnosis by sputum and bronchoalveolar lavage. South Med J 83: 1226–1229, 1990.
Berger R, Kraman S, Paciotti M: Pulmonary strongyloidiasis complicating therapy with corticosteroids. Am J Trap Med Hyg 29:31–34, 1980.
Higenbotham TW, Heard BE: Opportunistic pulmonary strongyloidiasis complicating asthma treated with steroids. Thorax 31: 226–233, 1976.
Meltzer RS, Singer C, Armstrong D, et al: Pulmonary strongyloidiasis complicating therapy with corticosteroids. Am J Med Sci 277:91–98, 1979.
Meyers AM, Shapiro DJ, Milne FJ, et al: Strongyloides stercoralis hyperinfection in a renal allograft recipient. South Afr Med J 50:1301–1302, 1976.
Nwokolo C, Imohiosen EAE: Strongyloidiasis of respiratory tract presenting as “asthma.” Br Med J 2:153–154, 1973.
Scoggin CH, Call NB: Acute respiratory failure due to disseminated Strongyloidiasis in a renal transplant recipient. Ann Intern Med 87:456–458, 1977.
Nolan TJ, Schad GA: Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 62:1038, 1996.
Cruz T, Reboucas G, Rocha H: Fatal Strongyloidiasis in patients receiving corticosteroids. N Engl J Med 275:1093–1096, 1966.
Cookson JB, Montgomery RD, Morgan HV, et al: Fatal paralytic ileus due to Strongyloidiasis. Br Med J 4:771–772, 1972.
Rassiga AL, Lawry JL, Forman WB: Diffuse pulmonary infection due to Strongyloides stercoralis. JAMA 230:426–430, 1974.
Naquira C, Jiminez G, Guerra JG, et al: Ivermectin for human Strongyloidiasis and other intestinal helminths. Am J Trap Med Hyg 40:304–309, 1989.
Ravdin JL Amebiasis. In Human Infection by Entamoeba histolytica. John Wiley, New York, 1988.
Sargeaunt PG, Jackson TFHG, Simjee AE: Biochemical homogeneity of Entamoeba histolytica isolates, especially those from liver abscess. Lancet 1:1386–1388, 1982.
Villarejos SVM: Corticosteroid and experimental amoebiasis in rats. J Parasitol 48:194, 1962.
Anaya-Velazquez F, Tsutsumi V, Gonzolez-Robles A, et al: Intestinal invasive amebiasis: An experimental model in rodents using axenic or monoxenic strains of Entamoeba histolytica. Am J Trap Med Hyg 34:723–730, 1985.
Allason-Jones E, Mindel A, Sargeaunt P, et al: Entamoeba histolytica as a commensal intestinal parasite in homosexual men. N Engl J Med 315:353–356, 1986.
Sullam PM: Entamoeba histolytica in homosexual men. N Engl J Med 316:690, 1987.
Antony MA, Brandt LJ, Klein RS, et al: Infectious diarrhea in patients with AIDS. Dig Dis Sci 33:1141–1146, 1988.
El-Hannawy M, Abd-Rabbo H: Hazards of cortisone therapy in hepatic amebiasis. J Trap Med Hyg 81:71–73, 1978.
Denis M, Chadee K: Immunopathology of Entamoeba histolytica infections. Parasitol Today 4:247–252, 1988.
Kretschmer RR: Immunology of amebiasis. In Martinez-Palomo A (ed): Amebiasis. Elsevier, Amsterdam, 1986, pp. 95–167.
Trissl D: Immunology of Entamoeba histolytica in human and animal hosts. Rev Infect Dis 4:1154–1184, 1982.
Nanda R, Baveja U, Annand BS: Entamoeba histolytica cyst passers: Clinical features and outcome in untreated subjects. Lancet 2:301–303, 1984.
Balikian JP, Bitar JG, Rishani KK, et al: Fulminant necrotizing amebic colitis in children. Am J Protocol 28:69–78, 1977.
Cardoso JM, Kimura K, Stoopen M, et al: Radiology of invasive amebiasis of the colon. J Roentgenol 128:935–946, 1977.
Rails PW, Barnes PF, Johnson MB, et al: Medical treatment of hepatic amebic abscess: Rare need for percutaneous drainage. Radiology 165:805–807, 1987.
Duma RJ, Ferrell HW, Nelson CE, et al: Primary amebic meningo-encephalitis. N Engl J Med 281:1315–1323, 1969.
Duma RJ, Finley R: In vitro susceptibility of pathogenic Naegleria and Acanthamoeba species to a variety of therapeutic agents. Antimicrob Agents Chemother 10:370–376, 1976.
Grimaldi G Jr, Tesh RB, McMahon-Pratt D: A review of the geographical distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 41:687–725, 1989.
Ma DDF, Concannon AJ, Hayes J: Fatal leishmaniasis in renal-transplant patients. Lancet 2:311–312, 1979.
Cerf BJ, Jones TC, Badaro R, et al: Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis 156:1030–1033, 1987.
Harrison LH, Naidu TG, Drew JS, et al: Reciprocal relationship between under nutrition and the parasitic disease visceral leishmaniasis. Rev Infect Dis 8:447–453, 1986.
Pampiglione S, Manson-Bahr PEC, Giungu F, et al: Studies on Mediterranean leishmaniasis. II. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trap Med Hyg 68:447–453, 1974.
Aguardo JM, Gomez J, Figuera A, et al: Visceral leishmaniasis complicating acute leukemia. J Infect Dis 7:272–274, 1983.
Aguardo JM, Plaza J, Escudero A: Visceral leishmaniasis in renal-transplant recipient. J Infect 13:301–302, 1986.
Badaro R, Carvalho EM, Rocha H, et al: Leishmania donovani: An opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 1:647–649, 1986.
Broeckaert A, Michielsen P, Vandepitte J: Fatal leishmaniasis in renal-transplant patient. Lancet 2:740–741, 1979.
Fernandez-Guerrero ML, Aguado JM, Buzon L, et al: Visceral leishmaniasis in immunocompromised hosts. Am J Med 83:1098–1102, 1987.
Ma DDF, Concannon AJ, Hayes J: Fatal leishmaniasis in a renal transplant patient. Lancet 2:311–312, 1979.
Montalban C, Martinez-Fernandez R, Calleja JL, et al: Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 11:655–660, 1989.
Yebra M, Segovia J, Manzano L, et al: Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome. Ann Intern Med 108:490–491, 1988.
Berenguer J, Gomez-Campdera F, Padilla B, et al: Visceral leishmaniasis (kala-azar) in transplant recipients: Case report and review. Transplantation 65:1401–1404, 1998.
Weiser WY, Van Neil A, Clark SC, et al: Recombinant human granulocyte/macrophage colony stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med 166:1436–1446, 1987.
Carvalho EM, Teixeira R, Johnson WD: Cell mediated immunity in American visceral leishmaniasis: Reversible immunosuppression during acute infection. Infect Immun 33:498–502, 1981.
Badaro R, Reed S, Barral A, et al: Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies to American visceral leishmaniasis: Standardization of parasite antigen to detect infection-specific responses. Am J Trap Med Hyg 35:72–78, 1986.
Navin TR, Arana BA, Arana FE, et al: Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 165:528–534, 1992.
Hoskins LC, Winawer SJ, Broitman SA, et al: Clinical giardiasis and intestinal malabsorption. Gastroenterology 53:265–279, 1967.
Keysteon JS, Krajden S, Warren MR: Person-to-person transmission of Giardia lamblia in day care nurseries. Can Med Assoc J 119:241–248, 1978.
Smith PD, Keister DB, Elson CO: Human host response to Giardla lamblia trophozoites. II. Antibody-dependent killing in vitro. Cell Immunol 82:308–315, 1983.
Hermans PE, Huizenga KA, Hoffman HN, et al: Dysgammaglobulinemia associated with nodular lymphoid hyperplasia of the small intestine. Am J Med 40:78–89, 1966.
Jones EG, Brown WR: Serum and intestinal fluid immunoglobulin in patients with giardiasis. Am J Dig Dis 19:791–796, 1974.
Roberts-Thomson IC, Stevens DP, Mahmoud AA, et al: Acquired resistance to infection in an animal model of giardiasis. J Immunol 117:2036–2037, 1976.
Roberts-Thomson IC, Mitchell GF: Giardiasis in mice. I. Prolonged infections in certain mouse strains and hypothymic (nude) mice. Gastroenterology 75:42–50, 1978.
Stevens DP, Frank DM, Mahmoud AAF: Thymus dependency of host resistance to Giardia muris infection: Studies in nude mice. J Immunol 120:680–682, 1978.
Zinneman HH, Kaplan AP: The association of giardiasis with reduced intestinal secretory immunoglobulin A. Am J Dig Dis 17:793–797, 1972.
Ament ME, Rubin CE: Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes. Gastroenterology 62:216–226, 1972.
Stevens DP, Frank DM: Local immunity in murine giardiasis: Is milk protective at the expense of maternal gut? Trans Assoc Am Physicians 91:268–272, 1978.
Owen RL: Sexually related intestinal disease. In Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease, 3rd ed. Saunders, Philadelphia, 1983, pp. 966–985.
Philips SC, Mildvan D, William DC, et al: Sexual transmission of enteric protozoa and helminths in a venereal disease clinical population. N Engl J Med 305:603–606, 1981.
Schmerin MJ, Jones TC, Klein H, et al: Giardiasis: Association with homosexuality. Ann Intern Med 88:801–803, 1978.
Janoff EN, Smith PD, Blaser MJ: Acute antibody responses to Giardia lamblia are depressed in patients with the acquired immunodeficiency syndrome. J Infect Dis 157:798–804, 1988.
Balck RE, Dykes AC, Sinclair SP, et al: Giardiasis in day care centers: Evidence of person-to-person transmission. Pediatrics 60:486–491, 1977.
Barbour AG, Nichols CR, Fukushima T: An outbreak of giardiasis in a group of campers. Am J Trap Med 25:384–389, 1976.
Brodsky RE, Spencer HC, Schultz MG: Giardiasis in American travelers in the Soviet Union. J Infect Dis 130:319–323, 1974.
Butler T, Middleton FG, Earnest DL, et al: Chronic and recurrent diarrhea in American servicemen in Vietnam. Arch Intern Med 132:373–377, 1973.
Dykes AC, Juanek DD, Lorenz RA: Municipal water-borne giardiasis: An epidemiologic investigation: Beavers implied as a possible reservoir. Ann Intern Med 92:165–170, 1980.
Shaw PK, Brodsky RE, Lyman DO, et al: A community-wide outbreak of giardiasis with documented transmission by municipal water. Ann Intern Med 87:426–432, 1977.
Morecki R, Parker JG: Ultrastructure studies of the human Giardia lamblia and subjacent jejunal mucosa in a subject with steatorrhea. Gastroenterology 52:51–164, 1967.
Sheehy TW, Holley HP Jr: Giardia-induced malabsorption in pancreatitis. JAMA 233:1373–1375, 1975.
Tandon BN, Tandon RK, Satpathy BK, et al: Mechanism of malabsorption in giardiasis: A study of bacterial flora and bile salt deconjugation in upper jejunum. Gut 18:176–181, 1977.
Saha TK, Ghosh TK: Invasion of small intestinal mucosa by Giardia lamblia in man. Gastroenterology 72:402–405, 1977.
Tapper ML, Armstrong D: Malaria complicating neoplastic disease. Arch Intern Med 136:807–810, 1976.
Healy GR: Babesia infections in man. Hosp Pract 13:107–116, 1979.
Healy GR, Wlazer PD, Sulzer AJ: A case of asymptomatic babesiosis in Georgia. Am J Trop Med Hyg 25:376–378, 1976.
Ruebush TK II, Spielman A: Human babesiosis in the United States. Ann Intern Med 88:263, 1978.
Ruebush TK II, Cassaday PB, March JH, et al: Human babesiosis on Nantucket Island: Clinical features. Ann Intern Med 86:6–9, 1977.
Ruebush TK II, Juranek DD, Chisholm ES, et al: Human babesiosis on Nantucket Island: Evidence for self-limited and subclinical infections. N Engl J Med 297:825–827, 1977.
Chisholm ES, Ruebush TK II, Sulzer AJ, et al: Babesia microti infection in man: Evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 7:14–19, 1978.
Miller LH, Neva FH, Gill F: Failure of chloroquine in human babesiosis (Babesia microti). Ann Intern Med 88:200–202, 1978.
Rowin KS, Tanowitz HB, Wittner M: Therapy of experimental babesiosis. Ann Intern Med 97:556–558, 1982.
Ashford RW: Occurrence of an undescribed coccidian in man in Papua New Guinea. Ann Trop Med Parasitol 73:497–500, 1979.
Ortega YR, Sterling CR, Gilmann RH, et al: Cyclospora species— A new protozoan pathogen of humans. N Engl J Med 328:1308–1312, 1993.
Hoge CW, Shlim DR, Rahaj R, et al: Epidemiology of diarrhoeal illness associated with coccidian-like organism among travellers and foreign residents in Nepal. Lancet 341:1175–1179, 1993.
Hart AS, Ridinger MT, Soundarajan R, et al: Novel organism associated with chronic diarrhoea in AIDS. Lancet 335:169–170, 1990.
Long EG, White EH, Carmichael WW, et al: Morphologic and staining characteristics of cyanobacterium-like organism associated with diarrhea. J Infect Dis 164:199–202, 1991.
Fishman JA: Prevention of infection due to P. carinii in transplant recipients. Clin Infect Dis 33:1397–1405, 2001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Fishman, J.A. (2002). Pneumocystis carinii and Parasitic Infections in the Immunocompromised Host. In: Rubin, R.H., Young, L.S., Van Furth, R. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/0-306-47527-8_8
Download citation
DOI: https://doi.org/10.1007/0-306-47527-8_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46693-9
Online ISBN: 978-0-306-47527-6
eBook Packages: Springer Book Archive